Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07049900 · ClinicalTrials.gov registry record · NA

Baby ABS (Abdominal Binder Study)

A NA study of Premature and Premature Lungs, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07049900: Recruiting NA study of Premature and Premature Lungs, sponsored by University of Minnesota.

NCT07049900 is a NA study of Premature and Premature Lungs that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 225-participant average among 4 other Premature trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07049900, a NA study of Premature and Premature Lungs, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.

Primary Outcome

Thickness measured by ultrasound

Interventions

  • DEVICE NeoBelly Band

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-22
Est. Completion 2027-02-28
Phase NA
University of Minnesota

966 total trials

What NCT07049900 shows while recruiting

NCT07049900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 225-participant average among 4 other Premature trials with a reported enrollment target (82% lower).

The record links to 4 conditions, with Premature appearing as the primary indexed condition, and to 1 intervention - of which NeoBelly Band is the first listed.

NCT07049900 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07049900 about?

NCT07049900 is a clinical study titled "Baby ABS (Abdominal Binder Study)". The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier correct...

What is the current status of trial NCT07049900?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-22. Estimated completion is 2027-02-28.

What conditions does trial NCT07049900 study?

This clinical trial studies the following conditions: Premature, Premature Lungs, Ventilator Lung; Newborn, Rectus Abdominis.

What interventions are being tested in trial NCT07049900?

The interventions under investigation include: NeoBelly Band (DEVICE).

Who is sponsoring clinical trial NCT07049900?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07049900 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07049900, the US trial registry maintained by the National Library of Medicine. NCT07049900 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.